Close

Interviews

OneSource Specialty Pharma: Revolutionizing CDMO Services with End-to-End Solutions – An Exclusive Interview with CEO Neeraj Sharma at CPHI Milan 2024

This interview features Mr. Neeraj Sharma, CEO of OneSource Specialty Pharma, a newly established Contract Development and Manufacturing Organization (CDMO) formed by merging three businesses within the Strides Group. With a legacy of over 30 years of Strides Group,...

Revolutionizing Gene-Editing: An Inside Look at the ReciBioPharm and Hongene Partnership

World Pharma Today's latest interview centers on the groundbreaking partnership between ReciBioPharm and Hongene, focused on advancing gene-editing drug development and manufacturing. The companies share a vision to make high-quality, accessible gene-editing solutions available to patients, driving advancements in life-saving...

Strategic Leadership Competencies for Today’s CDMOs: A Q&A with Morten Nielsen and Mindy Steiger of WittKieffer

The CDMO landscape has shifted dramatically in just the past few years, with the competencies required to lead these organizations evolving to align with changing strategic priorities. In the following conversation, Morten Nielsen and Mindy Steiger of WittKieffer, the...

Korea Biopharma Excellence Awards Q&A – World Pharma Today (Oct)

World Pharma Today, recently got in touch with Roquette’s Dr. Vinod Tuliani, where he spoke extensively about the accolades for the company, the innovations that are taking place in the biopharmaceutical space, and how the company has come of...

AI not just for data crunching but better patient outcomes – Dominic Marasco from Envision Pharma Group

In Conversation with Dominic Marasco: AI Beyond Data Crunching for Better Patient Outcomes In this exclusive interview with World Pharma Today, Dominic Marasco, a leader at Envision Pharma Group, delves into the transformative role of artificial intelligence (AI) in the...

N4 Pharma’s CEO Nigel Theobald Discusses Strategic Moves and Future Outlook in Pharma

In an interview with Nigel Theobald, CEO of N4 Pharma, several key points emerged regarding the company's recent strategic moves and its outlook in the pharmaceutical landscape. 1. Can you provide more insight into the decision to acquire a controlling...

Addressing The Male Infertility Crisis: Fertility Expert Mats Holmberg Unveils Latest Advancements in Male Infertility – From Clinical Trials To Research and Reasoning

In an interview with Mats Holmberg, a fertility expert, the significance of male infertility in today's context is highlighted. Male infertility contributes significantly to overall infertility rates globally, with notable declines in sperm count and quality over the past...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read